{"name":"Advanz Pharma","slug":"advanz-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPa3c0ZExvQXc4UE56MDI4U0phVFFBaVdWSFlRbm1aWUstS3E2NGozbU45QUU5eHNUcEMtbjQ2YjRvZmNMVS1VeEVIOTRFWjIzU005cGZnV3lWTmZtZVM0a2d2MUN3Qm85M1hFaS1CVWFnbGduRUZOcFJjYnZ5VHM0YnNuRUFDdU5Vbzk5QkdYdEJlZkJtc09fYWlSWVM?oc=5","date":"2026-03-26","type":"pipeline","source":"openPR.com","summary":"Sjogren's Syndrome Market Set to Boom Rapidly by 2033 |ADVANZ - openPR.com","headline":"Sjogren's Syndrome Market Set to Boom Rapidly by 2033 |ADVANZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ2w1WG9sRUtaZk9UVlpVZTdZSS1KUGYwVU51X3hGSXBid0dhblVtOWM1enRQU1Uyei13dG5jWnpSVjNOaTZTZkRhUWtjMWZMUlJKUnowMnRhenhrV1VzQV81WW1iTGQ1QXpISk1kWmFVeFVSUVZMZzdsM2h1NnVJTUdQX2owVDFJeVJLZmR5aVFha09mLUZ1Z3lwaGRqN0hGXzF5eGNjRmM4a3FJVjBN?oc=5","date":"2026-01-09","type":"patent","source":"JUVE Patent","summary":"Regional Court Munich grants PI to Regeneron against generics in Eylea case - JUVE Patent","headline":"Regional Court Munich grants PI to Regeneron against generics in Eylea case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPckdaYlRJSHY5VDI2clQyQ0R5em9FT0o1NzJaU2hPeE9mTXNzaFctV0E2Nnp6aGliaGNNYmM2THRYSXR0TkpxQ2ZZQ3M2aEpQY0cxX2ZqS3VhXzFqYkJCWEs3eFBVMEVqYWxCNU5rbzZkNE4tLUdPbjVRem5OdXY4LU96YVZaa0ltZnV4SHVwcUg2a0czX01SNzRNdndHa2VvcWI0WF9xTHREeUpyS1o5LXFoSlduaWxUYldsSjlDekZDRmd1Y2xiM0lGOWpubHpNQ28yNkxaMzd3dGVTZXhCRDdGOXFxUQ?oc=5","date":"2026-01-08","type":"patent","source":"pearceip.law","summary":"German Court Grants PIs Preventing Marketing of Aflibercept Biosimilars by STADA, Hexal, Celltrion and Advanz Pharma - pearceip.law","headline":"German Court Grants PIs Preventing Marketing of Aflibercept Biosimilars by STADA, Hexal, Celltrion and Advanz Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOdk1pUHFNa3VPN2FqV0l3UU4wMWwwX010NXNMTlhkU25qd0NMenJvSmlFT0IzT0R0dklDZDRmd19YcHZ2NHlRaXBYSkZZT1dTTDZTRjZkSVozeEVCY1FfMDMyWWNIdjB6YXZmRjBPMWEyRnZKSWxiOU9KRHo3d3RfZw?oc=5","date":"2025-11-21","type":"regulatory","source":"Pharmaceutical Technology","summary":"Alvotech and Advanz announce EC approval for Gobivaz biosimilar - Pharmaceutical Technology","headline":"Alvotech and Advanz announce EC approval for Gobivaz biosimilar","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNdEdUMW1KUE0xWkV1MDJweFZPMzNVYXVYbHFsMnF1QUFCdkNQWVpkRXNUOFNqRHpwdldtVFMtVjl3TWZWWUxLeUctMDJTQnZsN1BWaFkzekJST2lnNlM0djU5cXQyYlBhLWRTYlRsbDAtaUhRdUhjdkU5YXJSZVo0ZnpIYVZscWlvZWVWN0NHaU0zdw?oc=5","date":"2025-11-20","type":"regulatory","source":"pharmatimes.com","summary":"Gobivaz approved across Europe as first Simponi biosimilar - pharmatimes.com","headline":"Gobivaz approved across Europe as first Simponi biosimilar","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOaTJMYmRpRi1JaTIyOHJvX2RPbUJrNXFXaXJBdEJObTBQMUQxMzhVa2tZV1dtTDdrQ1hQMkp3TUVJN1R4OGw4X3RWMkg5RkJQTDBKckFSRU80T0I4Q3NEdHY5cllxTkF4UWpzN0ZUMmpXdjFWYTF2X0dfVTYwTjlCMFE4RDhickh6aGs4enI0QWFGXzFGbVc2RlhvNFVPTkZzZ2Z5WC1iNFREbWFackNVWkk2VQ?oc=5","date":"2025-11-20","type":"regulatory","source":"The Pharma Letter","summary":"Alvotech and Advanz win EC approval for first Simponi biosimilar - The Pharma Letter","headline":"Alvotech and Advanz win EC approval for first Simponi biosimilar","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNaWJCOWV1YXc4czA3NWhHbkNxbi1hcG9SaXlMcnFfMnlXemVjQjg2N1NRYkZ1UkFESEFZSEhZODZKOGFRWTRHYUNYTmVic2dNWHJLbko1ZHJyMGVjRDNmTDRQY1lZd3Q1TWpzdXgwM1pTU3RpbWNKVzRJaWtYYkd2ZkNhYWtXeU1SVEk5MnFDOGtZU3NjRnJWT1pCSzRDemxnNEpBMGUwandoNjhfMGZxMjBvU2NKeXhkTlE?oc=5","date":"2025-11-06","type":"pipeline","source":"Contract Pharma","summary":"Alvotech, Advanz Pharma Receive MHRA Marketing Authorizations for Gobivaz - Contract Pharma","headline":"Alvotech, Advanz Pharma Receive MHRA Marketing Authorizations for Gobivaz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxPNGc2U0xPX1A1cWhMcG51bURrZkdIUmc1VGZkRE1TcEpueEFvRUpQQlZzbDd5R3lVNkxZYi02SV9tV0wzWGthRkRRRjdCUkN3dUJDMGw4NkVlVDNycVRVTlgzZDE1QTdKX0dOblVBbTBZMkQwVngyU2RKZWdXMnBhVzZkN1F1UTR1NXdpbzJ0eF9NOERWUjRNbm5oR0JTTmUwVE5KSjFfUFYtQkNTdGhqNkt4MjFqTWRHT2xhWnJKYUJkN3lmZ2p2RmptOXRHd1g5NTRBWERKWjY0SU02UzRVTktDVjFjd2h4YmZvNEpZUkpCaVZPSWJ4N1kxRFpzSXBIa3lxNW16a2ZRX0g3aTBHR0wyQnNibWRBMTVN?oc=5","date":"2025-11-06","type":"pipeline","source":"globenewswire.com","summary":"Alvotech and Advanz Pharma Receive Marketing Authorisations - globenewswire.com","headline":"Alvotech and Advanz Pharma Receive Marketing Authorisations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQSE5PblBobWJReEJzM0Vra281cGM4RXFnOVRNTTA1Tk9YR1BLOVJFQzNENTEzbDFBU0hCeWo2dTVlV1lYNWIyLWdlSGwzTjZjcHhzMnJ6T3R5T1BPaTkxSF9qanQ1aUVXclZMeHpobkxXUUlFUVFnS0cwOG9RVGE4R0lvcGhXQVBuN1ZTaEtoQmlRNVliWFR3?oc=5","date":"2025-09-22","type":"regulatory","source":"Yahoo Finance","summary":"European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner - Yahoo Finance","headline":"European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimum","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPc1Q3M25GWW5XU0hpSnNVYnlhTUtxUnZMNm91SDdUYkhFTGhaM3VLY2JtMEhuZzd4NDYzV3dwVzJqQ0dlUzZjTXZJQnVuREd6ZFlsVTBGOXctREczclRoWDFHSlFoUFdKc3p6Mi1HRTN6bUNQV0lELXlFWVhrbzUxZG5sZ2hMTF84MExVN01KN29XTk5YVWVnX05HWkhZMDNwcGc?oc=5","date":"2025-08-25","type":"regulatory","source":"Drug Store News","summary":"Advanz Pharma, Alvotech receive European approval for Mynzepli, biosimilar to Eylea - Drug Store News","headline":"Advanz Pharma, Alvotech receive European approval for Mynzepli, biosimilar to Eylea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOeDM5RllvRS1RX1pWaXM2MzFOZ29RMTB5N0NKMWdMbzlCc2RrczZBTmVwSVRnWENON1FJY2VjRF9sQnB6QmdmeFU1akM1TWtoYnMtc2lVWWtfdWVONkhpa3J2XzZzV19YSlFmaDM5bi1OSTEzRXA3THIyUlF2M29IVkUzakFVQmI3SkJBellOTUdxUnp4QWFhQnFzeEVTY3EyY0JTNG5yRnJTZnNiYzZNRE9yU1JVUVNWMFhMb0xkSVIzUTZIeWoxdnhnNU1aNTZp?oc=5","date":"2025-08-20","type":"deal","source":"PR Newswire","summary":"LSPedia and Spring Bio Solution Partner to Advance Pharma Traceability in India - PR Newswire","headline":"LSPedia and Spring Bio Solution Partner to Advance Pharma Traceability in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOUlBjQ19QdDRMS0ZnUnM4THpEVURMZE02Q0tPU2ZpZ2NtN1ZKODZfcU5aUzFqZUdhbW9GbWF4Vk1WZ3dfQXlqVXJIc3B6bjFHVkNObE9hdG5sTHU5SmptRk1qSzVnV0pGWnRiRTRweWRkZkZBdTNrLUxyb2xkeHNybExxRVNxUEFlREw4U2RSMmgxQUc3WVphbGJBMC1zM2xXOGZCMmlxV0UtNkZhOE1kNy1FQTV5QjQyVTk3UHFoNlMwTXdJbEhMM0c3N3hYd0dIZFE?oc=5","date":"2025-06-19","type":"deal","source":"World Pharmaceutical Frontiers","summary":"ADVANZ PHARMA acquires Testoviron rights from Bayer in Europe and parts of LATAM, MEA, and APAC - World Pharmaceutical Frontiers","headline":"ADVANZ PHARMA acquires Testoviron rights from Bayer in Europe and parts of LATAM, MEA, and APAC","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}